.
.
the report "correctly points out that there really was no playbook for dealing with what was an unprecedented health crisis," san diego mayor kevin faulconer said.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
customize your news feed by choosing the topics that interest you.
.
advertisement
.
tam - ?????
.